Jeffrey K. Belk
Peter Cowhey, PhD
Casper de Clercq
Moshe Engelberg, PhD
Seth Feuerstein, MD, JD
M. Wainwright Fishburn
Rosemary Kennedy, PhD
Jack Kreindler, MD
Brian Otis, PhD
Jordi Pons, PhD
Rena Rosenberg, PhD
Mike Shabot, MD
Glenn Steele, MD, PhD
Steven R. Steinhubl, MD
Eric Topol, MD
Jordan VanLare, MD
Conrad Wang, MD
Yulun Wang, PhD
Steven G. (Steve) Auerbach recently joined Alegeus Technologies as Chief Executive Officer and a member of its Board of Directors. Steve brings over 25 years of experience in healthcare benefits, including roles as President of Connextions and senior leadership positions with UnitedHealth Group, ChannelPoint and Cigna. With a singular focus on making customers successful, Steve has a proven track record of driving organizational growth by offering differentiated value, providing excellent customer service, and creating outstanding consumer experiences. Most recently, Steve served as President of Connextions, driving strong business growth and leading its transition from a BPO service provider to becoming the preeminent technology and solution provider for the healthcare market. He previously served as Executive Vice President of Operations at UnitedHealth Group, where he led 10,000 professionals providing service to more than 25 million consumers and 650,000 physicians. Steve holds a Bachelor of Arts degree in Mathematics and Statistics from the University of Connecticut and an MBA from the University of Hartford.
Josh is a former Bloomberg technology reporter and financial professional turned developer and serial entrepreneur. He is the founder of Velocity Kick, the first set of crowdfunding analytics tools aimed at improved audience and message management. Most recently, Josh led a financial data consulting and trading business, Visual Systems Research Group and VSRG Capital. Previously Josh worked as a portfolio manager at SAC Capital Advisors, LLC in Greenwich, Conn., managing technology investments. Prior to that, he held the role of Associate Analyst at Legg Mason Equity Research covering the wireless and technology sectors.
Jeffrey K. Belk
Co-Founder & CEO, Velocity Growth
Managing Director, ICT168 Capital, LLC
With over 30 years of Technology Company experience, Jeff served in several executive positions during more than 14 years at Qualcomm, including Senior Vice President, Strategy and Market Development, as well as Senior Vice President of Global Marketing. He initiated Qualcomm’s global branding, taking over marketing when it was a team of 6 people in 1995, and building the global marketing organization and brand that it is today. Prior to Qualcomm, he spent 12 years in sales, marketing, and product management in several high-growth tech companies…both Apps and Hardware, and companies large and small. He currently serves on the Board of Directors of Interdigital Corporation (NASDAQ: IDCC), and San Diego-based Peregrine Semiconductor Corporation (NASDAQ: PSMI), The Wireless Life Sciences Alliance, and the UC San Diego Alumni Association. He also is on the advisory board of CommNexus, a leading San Diego technology trade organization. Jeff has made a broad range of angel investments and serves as an adviser to a number of privately held companies.
Peter Cowhey, PhD
Dean; Qualcomm Endowed Chair in Communications and Technology Policy
Dr. Cowhey is the Dean; Qualcomm Endowed Chair in Communications and Technology Policy at UCSD. Cowhey is an expert on U.S. foreign policy and technology policy. He has published extensively on comparative foreign policy and international issues involving Asia and the United States. He has also done extensive work on international trade, technology and investment policy. His special expertise is the international communications and information industries. His recent book is Transforming Global Information and Communication Markets: The Political Economy of Innovation, (with J. Aronson and D. Abelson), MIT Press (2009). He is currently working on a book manuscript on American Foreign Economic Policy with M. McCubbins.
Ph.D., University of California, Berkeley, 1977 (political science)
M.A., University of California, Berkeley, 1971
B.S.F.S., Georgetown University, 1970 (foreign service)
Casper de Clercq
Norwest Venture Partners
With over 30 years of experience, Casper is a veteran of the medical device and life sciences industry, having led marketing and commercialization efforts for companies that span the healthcare space. He brings extensive operating knowledge to Norwest Venture Partners, where he focuses on mid-to-late-stage investments in consumer and digital health, healthcare IT, medical devices and diagnostics, technology-enabled healthcare services, and specialty pharmaceuticals. He currently serves on the boards of Intersect ENT (NASDAQ: XENT), iRhythm Technologies, Telcare, and Crossover Health, and was previously on the board of Basis (acquired by Intel). Casper is also responsible for NVP’s investment in Misfit Wearables. Prior to NVP, Casper was a Partner at U.S. Venture Partners, where he invested in therapeutic companies from clinical development through commercialization. He made and managed investments in more than a dozen companies as a member of the healthcare team and served as a board member for AtheroMed, Ilypsa (acquired by Amgen), and Valeritas. Casper was also a private investor and board member with Innospine (acquired by Kyphon).
Global Head of Regulatory Affairs, Strategic Innovation and Policy
Hoffmann-La Roche Ltd & Genentech
Michael Doherty is the Global Head of Regulatory Affairs, Strategic Innovation and Policy, Hoffmann-La Roche Ltd and Genentech, located in San Francisco. He has been head of Regulatory Affairs, Hoffman-La Roche Ltd. since 2002. He started his career in 1986 in regulatory Affairs in the Cyanamid Company (Lederle), based in the UK working primarily in the field of antibiotics registration with the UK health authority. He then joined Sandoz where he led the regulatory group in the UK undertaking the first European filings under the mutual recognition and centralized procedures with the EU commission. In 1992, he joined Rhone Poulenc Rorer (RPR) and took on global regulatory responsibility for the respiratory and endocrinology portfolios. He later joined Astra (to become AstraZeneca) where he took firstly the head of the Respiratory and Inflammation regulatory team and then became global head of drug development regulatory affairs. In 2002, he joined Hoffman-La Roche as global head, regulatory Affairs based in Basel. Prior to working in the Pharma industry he worked at the University of Manchester UK and Christie Hospital in the regional endocrinology laboratory. He has a BSc in Biochemistry and a fellowship of the Institute of Medical Sciences, UK and a Diploma in Management studies from the University of Portsmouth, UK.
Moshe Engelberg, PhD, MPH
President & Chief Executive Officer
Dr. Moshe Engelberg is founder and CEO of ResearchWorks, a business consulting firm that helps health companies save more lives and make more money. Clients include Philips Healthcare, Draeger Medical, Scripps Health, Kaiser Permanente, CDC, CMS, and numerous others. Key services are 1) determining what products to develop that customers will buy, 2) creating better ways to market and sell them, and 3) branding and business models that win. ResearchWorks tells the truth, establishes deep customer intimacy, and money-back guarantees successful outcomes. Moshe excels at working with complex organizations on tough issues by focusing on results and ROI. As a consultant, speaker, writer, and adjunct professor, Dr. Engelberg applies his decades of real world experience and extensive academic credentials to inspire fresh thinking and new solutions. He delights audiences with his entertaining style and practical “how-to” tips and techniques. Moshe has extensively taught graduate courses and executive education, and is currently adjunct faculty in SDSU’s Graduate School of Public Health. He also serves on FDA’s Risk Communication Advisory Council, and is a Director on several Boards. Dr. Engelberg earned his doctorate from Stanford University in Communication. He grew up in Pittsburgh Pennsylvania and now resides with his family in San Diego California.
Seth Feuerstein, MD, JD
Chief Innovation Officer
Dr. Seth Feuerstein is Chief Innovation Officer at Magellan Health, who specializes in transferring technology from university researchers to the healthcare industry. He is also Assistant Clinical Professor of Psychiatry at Yale University School of Medicine. His current role at Magellan is related to the recent acquisition of Cobalt Therapeutics, LLC, a company he founded, along with other faculty members from Yale, as a data driven health solution provider concentrated in cognitive behavioral therapy. Dr. Feuerstein is currently focused on integrating behavioral and primary care tools.
M. Wainwright Fishburn
Wainwright Fishburn, Jr. is a founding partner of Cooley LLP’s San Diego office, a prominent venture capital attorney, and chair of the firm’s Digital Health group. As a recognized life science and digital health thought-leader, Wain is a frequent speaker at programs addressing industry issues, including a keynote at the 2014 and 2015 International CES Digital Health Summit, USC’s Body Computing Conference, Impact Forum and the Wireless-Life Sciences Alliance’s Convergence Summit. Wain is also serving as Co-Chair of the 2015 BIO Digital Health Forum at the BIO International Convention for the second consecutive year. As both a founder and as counsel, Wain has worked with venture capital-backed companies across a variety of fields. For example, in the field of genomic medicine, he works with groups that develop and deploy high-performance network technology for genomic research and medicine. He is on the Board of the Critical Path Institute, a public-private partnership created in part by the FDA, dedicated to integrating scientific advances into the development pathway. Mr. Fishburn has been widely recognized as a leading attorney in numerous publications, including among others, his recent recognition by The Daily Journal as one of California’s top attorneys. He was previously named by Nature magazine as being instrumental to the success of San Diego as a biotechnology hub.
Chief Executive Officer
Brett is a senior executive with more than 20 years of experience in selling and managing technology solutions within the healthcare, manufacturing and CPG industries. For the past decade, Brett has held leadership roles in healthcare organizations, setting the strategic market direction and product portfolio development for leading cloud-based analytics and data exchange solutions. He has a degree in Management Information Systems from Central Michigan University.
Archelle Georgiou, MD
Senior Advisor & Chair of the Health Executive Roundtable
Dr. Archelle Georgiou is a Senior Advisor and Chair of the Health Executive Roundtable at TripleTree. She is also the President of Georgiou Consulting and uses her broad base of career experiences to help companies with innovative, effective healthcare solutions ignite the change they need for meaningful adoption and improved business results. In addition, Archelle hosts weekly televised health segment as well as monthly health specials on KSTP, the ABC affiliate in Minneapolis-St. Paul. For thirteen years, Dr. Georgiou held senior executive positions at UnitedHealth Group and served as the Chief Medical Officer for UnitedHealthcare and Executive Vice President of Strategic Relations at Optum. Dr. Georgiou graduated from the Johns Hopkins University and received her medical degree from Johns Hopkins School of Medicine. She was board-certified in Internal Medicine and practiced in California.
SVP Corporate Development
Maneesh leads M&A, strategic partnership and alliances, and the CaféWell Connect partner program. He brings a cross-disciplinary background of finance, investing, product development and engineering. Prior to joining Welltok, Maneesh was a Managing Director with Miramar Venture Partners, a leading early stage investor focusing on the information technology space. With Miramar, Maneesh led investments and was an advisor and board member for several health and consumer Internet companies. Before entering the venture world, Maneesh was an early employee with Broadcom, a Fortune 500 Company, leading product development and engineering efforts in more than a dozen communications technology solutions. Maneesh earned a bachelor’s degree in biomedical engineering from Worcester Polytechnic Institute, a master’s in electrical engineering from the University of Southern California, and an MBA from the Anderson School of Management at the University of California, Los Angeles.
Chief Executive Officer
Devin Gross has spent the last 20 years advocating for patient-centered care as an industry standard and establishing patient engagement as a solution to improve business outcomes for healthcare organizations. At Emmi Solutions, Devin fosters an atmosphere of collaborative innovation with emphasis on providing the highest quality client service and support. He guides the company in its mission to empower people in their health and transform healthcare through technology-based solutions. Prior to joining Emmi Solutions in 2003, Devin held roles as a Hospital Administrator and Healthcare Information Technology Consultant, which provided him a multi-faceted perspective on the healthcare industry. Regularly invited to share his insight, he has presented at events and conferences on topics such as patient empowerment, behavioral economics and leveraging technology to improve outcomes. Devin holds a Bachelor’s degree from Lehigh University and an MBA in Healthcare Administration from Temple University.
Founder & CEO
Ron Gutman is an inventor and a serial technology entrepreneur who has started and built several successful companies in digital health. He’s currently the Founder and CEO of HealthTap, the fastest growing digital-health startup that is helping many millions everywhere find the best care and make better decisions about their health and well-being. HealthTap has saved numerous lives and is helping everyone everywhere feel good by connecting them with a network of over 67,000 U.S. doctors for answers, tips, checklists, news, and live Virtual Consults. Ron is responsible for the company’s vision, innovation, products, and growth. Ron is also a writer (he wrote a very popular TED book on the hidden powers of smiling and has contributed articles to Fortune, Forbes, etc.) and is a speaker in health and technology conferences (including TED, Stanford Medicine X, and Health2.0). Ron is also an angel investor and an advisor to health and technology companies.
Co-Founder & CEO
Doug Hirsch has 20+ years of experience building and managing community, health and entertainment products. As one Yahoo’s first employees, he conceived and/or managed product development for all of Yahoo’s community and communication products. In 2001, he was named General Manager of Yahoo! Entertainment. In 2005, Doug started as Vice President Of Production at Facebook. Doug co-conceived and launched Facebook Photos. In 2006, Doug founded DailyStrength, the web’s leading community for people with health and life challenges, which was acquired by ShareCare, Inc. in 2008. Currently, Doug is the co-founder and CEO of GoodRx, a startup that brings affordable prescription drugs to cash-paying and insured consumers. Doug is a magna cum laude graduate of Tufts University, with additional coursework at Oxford University and UCLA. Doug was accepted at the Stanford Graduate School of Business, but opted not to leave Yahoo to attend business school.
Lucian Iancovici is a Management Member at dRx Capital, and he also serves as an Investment Manager at Qualcomm Ventures, who makes investments through Qualcomm’s Life Fund. His background and experience in medicine lead him to believe that this is a transformative period in the healthcare space, especially given the renewed interest in performance and cost metrics prevalent today. In this context, Lucian is focused on wireless healthcare opportunities. Lucian has lead investments in Practice Fusion, Common Sensing, Edico Genome, Predilytics and has worked closely with Fitbit, Telcare, and Clearcare. Previously, Lucian worked at McKinsey & Company, where he spent most of his time in the North American healthcare practice advising on clinical and business model transformation for large hospital systems. Prior to McKinsey, Lucian was a board certified internal medicine doctor practicing in New York. Lucian trained in internal medicine at Columbia University Medical Center in New York and completed both medical school and his undergraduate studies at Tufts University.
Chief Executive Officer, Trial Fusion
Chief Digital Officer, Scripps Translational Science Institute
Donald Jones is a globally recognized leader in Digital Medicine (sometimes referred to as Wireless Health, Digital Health, Connected Health, or mHealth). He is sought out as a speaker, advisor and board member. He works with healthcare, pharmaceutical and medical device, OEM, Telcos and early stage companies. Donald Jones is the CEO of Trial Fusion, a company focused on commercializing digital health products by providing design and partnership expert advise and clinical, user experience and economic evidence required for their adoption. Jones also serves as the Chief Digital Officer of the Scripps Translational Science Institute, working with the renowned Eric Topol, MD, on the convergence of genomics and wireless health – digital medicine. He co-founded Scripps Digital Medicine, the world’s first clinical trial center focused on digital health and large data sets. For 11 years through 2014, he led Wireless Health Global Strategy and Business Development for Qualcomm. He is Founder and Chairman of the Wireless Life Sciences Alliance. Working with the XPRIZE Foundation and Qualcomm’s CEO, Jones conceived the $10 million Qualcomm Tricorder XPRIZE, a global competition for a consumer device which makes medical diagnoses. CommNexus recognized Donald Jones as 2014 Digital Health Innovator of the Year.
Merck GHI Fund
Max Kahn is a Managing Director and seeks opportunities in Technology Enabled Care, with a particular emphasis on solutions for Provider and Patient Engagement. Mr. Kahn currently serves as a member of the Board of Directors of Healthsense and PatientSafe Solutions. Mr. Kahn brings over 20 years of experience in health care and emerging company investing, business development, and strategy creation and implementation. Before Merck GHI, he was in the health care strategy and alliances group at Johnson & Johnson, responsible for their new business model strategies. Prior to J&J, Mr. Kahn worked in the health care and insurance practices at McKinsey & Co. and also as a health care services and health care information investment banker at Commonwealth Associates. Mr. Kahn holds a MBA from Columbia University and a B.A. from the University of Pennsylvania.
Rosemary Kennedy, PhD, RN, MBA, FAAN
Chief Nursing Officer
Sotera Wireless, Inc.
Dr. Kennedy, RN, MBA, FAAN, is Chief Nursing Officer for Sotera Wireless, Inc. Prior to this role, she was President and CEO of eCare Informatics, and also Faculty at Thomas Jefferson University School of Nursing. Most recently Dr. Kennedy was Vice President of Health Information of Technology at the National Quality Forum in Washington, DC. She has more than 30 years of expertise in the development and implementation of electronic health records with a focus on terminology, integration of evidence-based guidelines within the EHR, quality measurement, and clinical decision support. Dr. Kennedy has a proven, solid track record in delivering on-time and within budget. In addition to being an informatics domain expert, she holds many leadership roles through her work with the American Medical Informatics Association (AMIA) and Technology Informatics Guiding Educational Reform Board (TIGER). Dr. Kennedy is widely presented and published in the field of nursing informatics, clinical documentation and terminology standards. She is a fellow in the American Academy of Nursing and received the HIMSS 2009 Nursing Informatics Award as well as the top 25 women in healthcare award for 2009. She is currently on the TIGER board and sits on the safety council for the American Association of Medical Instrumentation. For many years, she was the Chief Nursing Informatics Officer for Siemens Healthcare Solutions.
CEO and Co-Founder
Tom Kottler is the CEO and Co-Founder of HealthPrize Technologies, a company that has developed an Internet and mobile-based platform that uses gaming dynamics, behavioral economics and proven concepts from consumer marketing to motivate patients to start and stay on their prescribed medications. HealthPrize is the fourth start-up venture that Tom has founded or been associated with as part of the initial management team. His first start-up, MedAptus, a healthcare IT company in Boston, is still going strong 12 years later. Celadon Science, now Advanced BioHealing (acquired by Shire in May 2011 for $750M), developsand markets cell-based wound care technology. VeinAid develops non-invasive technology to treat varicose veins, based on patents with Tom as a named inventor. Prior to his entrepreneurial career, Tom was on the management team of a mid-sized CRO (contract research organization) that conducted trials for pharmaceutical companies. He helped manage the growth and sale of that company to a Fortune 500 company, for one of the highest multiples ever paid for a privately held CRO. Prior to that, Tom practiced law for nine years in Chicago and Connecticut, doing litigation and corporate law. He received his undergraduate degree from Middlebury College and his law degree from The George Washington University.
Daniel Kraft, MD
Founder and Executive Director, Exponential Medicine
Medicine Track Faculty Chair, Singularity University
Founder & CEO, IntelliMedicine, & Bioniq Health
Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur and innovator. Dr. Kraft has over 20 years of experience in clinical practice, biomedical research and healthcare innovation. Daniel chairs the Medicine track for Singularity University and is Founding Executive Director for Exponential Medicine, a program which explores convergent, exponentially developing technologies and their potential in biomedicine and healthcare. His various TEDTalks have over 1 Million Views. Following undergraduate degrees at Brown University and medical school at Stanford, Dr. Kraft was board certified in the Harvard combined Internal Medicine and Pediatrics residency program at the Massachusetts General Hospital and Boston Children’s Hospital. He went on to complete Stanford fellowships in hematology/oncology & bone marrow transplantation, and extensive research in stem cell biology and regenerative medicine. He has multiple scientific publications (Nature and Science) and medical device, immunology and stem cell related patents through faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at University of California San Francisco. Dr. Kraft recently founded Bioniq Health, focused on enabling connected, data driven, and integrated personalized medicine. He is also the inventor of the MarrowMiner, an FDA approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell based regenerative therapies. Daniel is an avid pilot and has served in the Massachusetts and California Air National Guard as an officer and flight surgeon with an F-16 fighter Squadron. He has conducted research on aerospace medicine published with NASA, and was a finalist for astronaut selection. Dr. Kraft’s experience and vision in many ways epitomizes the kind of out-of-the-box thinking that is shaping, not only the future of healthcare, but also the future of wellness, prevention, and biopharma.
Jack Kreindler, MD
Dr. Jack Kreindler is a physician, physiologist and entrepreneur. Since 1997, Jack has been instrumental in the design, architecture and leadership of many innovative technology ventures in health care and the social web. Whilst practicing as an Emergency Physician from 2002 to 2006, Jack’s incubator BlueOrange Technologies developed the core technology platform for enterprises and high growth start-ups. In 2007 he founded the Center for Health and Human Performance (CHHP), renowned for its work with athletes, complex cases and celebrities taking on extreme challenges. The concept for Sentrian came out of CHHP’s work tackling complex chronic disease combining world experts, the latest biosensor technology and physiological modelling techniques from the worlds of medicine and elite sport science. Jack lectures internationally on the future of medicine and is a guest expert presenter for CNBC, Sky Sport, BT Sport and the BBC.
Scott Lambert is a Vice President for Ascension, the parent organization of Ascension Health, and leader of the Ascension’s Innovations Accelerator Team. The Innovation Accelerator Team is a catalyst in identifying and accelerating the development and spread of innovative care and business models which move Ascension Health toward is Strategic Direction. He oversees incubation of transformational solutions and innovative relationships that have the potential to accelerate accomplishment of Ascension Health’s vision and identify new health-related business models. Key areas of work for the Innovations Accelerator Team include: care models for those that are poor or vulnerable, health-related social entrepreneurism, virtual and remote care, and learning from international models. The Team also developed a number of relationships to inside and outside of healthcare with innovative thinkers and strategists including health accelerators, health and non-health thought leading groups and key industry groups. Mr. Lambert previously served in various research/development and innovation roles within the organization. These roles focused on everything from operational/clinical improvement initiatives to transformational initiatives such as retail health models. Prior to joining Ascension Health in 2003, he was a principal with the consulting firm Cap Gemini Ernst & Young. For most of his 20 year career in consulting, Mr. Lambert focused on strategy, operations and supply chain projects in Fortune 100 companies, many of which involved use of new or emerging technologies. In his last several years in consulting he transitioned to the same content areas within healthcare including helping Ascension Health optimize its supply chain. He started his career as a system analyst with McDonnell Aircraft Company. Scott earned a Bachelor of Science in Business Information Systems from Missouri State University in Springfield, Missouri.
Founder & Director
Mobile Heights Business Center
Marianne Larsson is the founder and Director of Mobile Heights Business Center and is still very hands on involved in advising IT and mobile companies. Prior to Mobile Heights Business Center she worked for 15 years in international business development at Tetra Pak and Alfa Laval, as well as nine years as an entrepreneur and management consultant in various industries. She is an advisor to Swedish IT Minister Anna-Karin Hatt and was one of the judges in the popular Swedish reality show Uppfinnarna (The Inventors) in TV4.
Partners Healthcare Innovation
Steve Lindseth has founded/co-founded companies in a variety of healthcare sectors including devices, technology enabled services, digital media and enterprise software. He is a consultant to Partners Healthcare Innovation (Massachusetts General and Brigham & Women’s Hospitals), Ariadne Labs (Atul Gawande) and Capella University. He is on the boards of Cleveland Clinic Innovations and Imagescan (transactional content management) and on the board of advisors of Healthprize, a prescription medication adherence company. Steve is also a senior advisor to Triple Tree Capital Partners. He co-founded YouBeauty, a women’s digital media wellness business with Dr. Mehmet Oz, sold in May of 2014. Prior ventures include Dental Research Corp, maker of the Interplak Toothbrush (sold to Bausch & Lomb), Thermoscan, maker of the Thermoscan Thermometer (sold to Gillette), Complient, outsource provider of emergency medical response services (sold to Cardiac Science), Axentis, provider of compliance software for the Pharmaceutical Industry (sold to Wolters Kluwer) and Explorys, provider of clinical big data management, (sold to IBM).
Co-Founder & COO
Romain is Co-Founder and Chief Operations Officer of Voluntis, a pioneer of therapeutic companion software since 2001. Voluntis innovates health care by embedding connectivity in therapeutics and medical intelligence in software. Active in diabetes, anticoagulation, oncology and hemophilia, Voluntis partners with pharma companies to build patient-centric solutions that leverage mobile and cloud technologies, and harness its proprietary data analytics platform. Headquartered in Paris and with offices in Boston, Voluntis recently completed a $27 million Series D financing round, one of the largest in the m-health sector in 2014. Romain has over 15 years’ experience in e-Health and m-health technologies, and is a graduate from Ecole Centrale Paris in applied mathematics.
Executive Vice President of Product & Marketing
Doug joined Fitlinxx from his previous venture-backed start-up company, Healthrageous, where he was the Co-Founder and Chief Technology Officer. Previous to that, he led the technology and operations teams at the Center for Connected Health at Partners HealthCare in Boston. Doug is a digital health expert with a successful track record in developing and commercializing IP and products in the consumer health engagement space. He specializes in leading product management and development in HIPAA compliant, FDA regulated device and experience markets. Doug has a BA from Drew University and an MBA in International Business from the University of Denver.
Erik Milch is a partner in the Patent Counseling & Prosecution practice group and a member of the Cooley Litigation department. He joined the Firm in 2000 and maintains offices in Reston and Palo Alto. Mr. Milch’s professional experience includes patent litigation, including enforcement of patents against competitors, and defense of patent infringement allegations, patent procurement, strategic counseling regarding the development of patent portfolios, patent licensing, valuation of patent portfolios in business transactions and transactional diligence. Prior to law school, Mr. Milch was a U.S. Naval Officer. During his tenure with the Navy, he served as a Naval Aviation Support Officer at the U.S. Naval Air Station in Keflavik, Iceland and with Air Test and Evaluation Squadron One in Patuxent River, Maryland. Mr. Milch received his law degree from the George Mason University School of Law in 1999. Mr. Milch received his Bachelor’s degree in mechanical engineering from the Georgia Institute of Technology in 1993 where he was the Naval Reserve Officer Association Honor Graduate.
Vice President of Technical Innovation
Advanced ICU Care
In his role as the Vice President of Technical Innovation, Marty Miller will oversee Information Technology and Information Security processes and operations as well as drive strategic IT Initiatives. Miller brings to Advanced ICU Care over 10 years of experience in healthcare IT leadership positions, including serving 8 years as Chief Information Officer, Chief Information Security Officer, and Chief Technology Officer at Children’s Hospital Los Angeles, ranked among the top 5 pediatric institutions in the United States, according to U.S. News and World Report. Prior to Children’s Hospital Los Angeles, Mr. Miller gained broad experience in IT and Information Security by serving in various leadership roles. Advanced ICU Care leverages Miller’s extensive expertise in healthcare IT to further augment our technological infrastructure, enhancing Advanced ICU Care’s ability to proactively anticipate and deliver on the needs of current and future hospital clients nationwide.
Chairman & CEO
Vital Connect, Inc.
Nersi is a veteran technology professional with more than 25 years of experience in the tech industry, with an emphasis in corporate management, business development and venture funding. Prior to co-founding Vital Connect, Nersi served as CEO of Teranetics Inc, which was acquired by PLX Technology. He also founded Pacific General Ventures, a private venture capital firm that invests in high technology companies. Currently, Nersi serves on the boards of several companies in the technology space. He earned a doctorate in electrical engineering from the University of Colorado and has been awarded eight U.S. patents.
Head of Integrated Care
Andrew leads the Integrated Care Center of Excellence, which focuses on partnering with our top customers to create innovative solutions that address the holistic needs of our patients beyond our drugs. Andrew joined Sanofi from Genzyme and has held leadership positions in marketing, business development, consulting and venture capital.
Brian Otis, PhD
Dr. Brian Otis is the founder of Google[x]’s smart contact lens project and is the Google[x] microsystems lead. He received a B.S. in electrical engineering from the University of Washington, Seattle, and a M.S. and Ph.D. degree in electrical engineering from the University of California, Berkeley. He joined the faculty of the University of Washington in 2005 where he runs a chip design research lab that designs tiny, low power chips for a variety of applications (neural recording, implants, wearable on-body wireless sensors, environmental monitoring, etc.). He is a member of the Technical Program Committee of the International Solid-State Circuits Conference (ISSCC) and is an Associate Editor of the Journal of Solid State Circuits (JSSC).
Julie joined Canaan Partners, a technology and healthcare venture capital fund with $4.2 billion under management, in 2013. As a Principal, she concentrates on biopharmaceutical, digital health and consumer medical device investments. Prior to joining Canaan Partners, Julie worked at Genentech in a variety of roles spanning business development, development and commercial primarily within oncology and endocrinology. At Canaan, Julie helped shape the firms’ beyond the pill investment strategy which includes new investments in Chrono Therapeutics, Glooko and Truveris. She currently observes the boards of Cellular Research, ALDEA Pharmaceuticals, Chrono Therapeutics, Glooko, and CytomX Therapeutics. Julie earned her MBA from Stanford¹s Graduate School of Business, MPhil from Cambridge in BioScience Enterprise and B.S. from Yale in Molecular Biophysics and Biochemistry.
Senior Vice President & Chief Information Officer
A 29-year veteran of HCA, Paslick leads the company’s Information Technology & Services department (IT&S), which provides IT strategy and support for HCA and its 165 hospitals. IT&S has more than 4,300 employees across the U.S. and includes four data centers and 13 division support centers responsible for delivering IT services to HCA, as well as more than 80 non-HCA facilities. The department’s array of services includes business analysis, systems development, systems integration, information security, customer support, training and education, and infrastructure support. Paslick is also organizationally responsible for the company’s first technology company acquisition, PatientKeeper. During his career at HCA, Paslick has led the development of new IT units to pursue business opportunities and the transformation of the organization’s field-based IT operations. He became responsible for the day-to-day operations of IT&S when he was named the department’s Chief Operating Officer in 2010. Paslick was appointed HCA’s CIO in June of 2012. Paslick is past Chairman of the Board of the Nashville Technology Council, and past Board Member of the Nashville Chamber of Commerce. He is the current chairman of Nashville Sports Council Board. Paslick holds two undergraduate degrees and an MBA, all from the University of Louisville. He and his wife Becky live in Nashville and have one son.
Jordi Pons, PhD
Dr. Jordi Serrano Pons is a General Practitioner and the founder of UniversalDoctor, a suite of digital health apps and webs to facilitate multilingual communication between health care professionals and patients that don’t speak the same language. UniversalDoctor was launched in Barcelona some years ago and has since won several awards for its web and mobile applications, including the United Nations World Summit Award as Global Champion for the mHealth category this last February. Jordi is a widely recognized and active participant in the digital health field, both in Europe and abroad, who has combined his knowledge as a physician and entrepreneur to successfully introduce digital health tools in various healthcare settings. Jordi is also working as a Consultant at WHO as advisor on Innovation and Health. He collaborates with a number of regional and national governments at the European level and Universities specifically focusing on health and technology. Jordi holds also a Master’s degree in Health and Environment and a Postgraduate degree in International Studies from the University of Barcelona. He currently resides in Geneva, Switzerland.
Rena Rosenberg, PhD
Partner, Pharma & Medical Products Practice
McKinsey & Company
Rena is a Partner in McKinsey’s New Jersey office. Rena leads our special initiative in Data, Analytics, and Digital within the Pharmaceuticals and Medical Device Practice. Areas of expertise: Rena has worked across large and mid-size pharmaceutical companies with a strong focus in Corporate Strategy, Marketing, Sales, and Medical Affairs. More recently, Rena has spent time building and deploying McKinsey’s Healthcare Digital capabilities helping clients leverage data and technology to address their critical business issues across the value chain with a focus on customer engagement and big data analytics. Relevant experience: In the pharmaceutical commercial space, Rena has worked on several topics including the development of new selling models including leveraging innovative new technologies and digital channels at the corporate level and at the brand level across the product lifecycle and across therapeutic areas. Rena also works in other areas of healthcare including with payors on post-Healthcare Reform strategy. Educational background: Rena has a Ph.D. in Economics from the University of Chicago with a focus on human capital and healthcare, and B.A. in economics from Barnard College, Columbia University.
Mike Shabot, MD
Executive Vice President & Chief Clinical Officer
Memorial Hermann Health System
M. Michael Shabot, M.D. is Executive Vice President and Chief Clinical Officer for the Memorial Hermann Health System in Houston, Texas, which includes nine acute care hospitals, a children’s hospital, two rehabilitation hospitals, 20 ambulatory surgical centers and 180 other ambulatory facilities. He is responsible for Memorial Hermann’s medical groups with 4,000 physicians, its Accountable Care Organization, a primary care residency, Health Information Management, Case Management, Care Management, Medical Informatics, Quality, Safety, Infection Control and Registry Reporting. In 2013 the Memorial Hermann ACO generated the highest savings the CMS Medicare Shared Savings Program has ever recorded, over $57.8M. Dr. Shabot is an Adjunct Professor at the University of Texas at Houston in the Schools of Biomedical Informatics and Public Health. He serves on the Board Quality Committee of the Mercy System in St. Louis, MO. Under his leadership, in 2013 Memorial Hermann received the John M. Eisenberg Award for Patient Safety and Quality at the National Level, presented by the Joint Commission and National Quality Forum. Thomson Reuters rated Memorial Hermann one of the top 5 large US healthcare systems in 2012 and 2013. In 2012 the system received the Texas Hospital Association’s Bill Aston Quality Award for its high reliability program. In 2009 Memorial Hermann received the National Quality Healthcare Award from the National Quality Forum as well as the National Patient Safety Leadership Award from the VHA Foundation and National Business Group on Health. The book Integrating Quality and Strategy in Health Care Organizations, coauthored by Dr. Shabot, was published in August 2012.
Chief Executive Officer
Mobilium Global Limited
Ralph Simon is acknowledged as one of the founders of the modern mobile entertainment industry. Over the last 15 years, he has been a prominent global mobile trailblazer and innovator, helping grow the mobile entertainment and content industry, and playing a central role in its impact and presence worldwide. Simon heads the London-based Mobilium International, which provides high-level strategic advice and guidance to mobile handset makers, telco operators, technology companies, media companies, movie studio & TV networks, global music artists, ad agency groups, brands, and platform providers around the world. In late 2013, Mobilium Africa launched the first comprehensive, pan-African and Africa-specific mobile health delivery network known as Smart Health Hub. Mobilium Africa has licensed the innovative Smart Health Hub health and wellness platform to Samsung, one of the world’s largest mobile device manufacturing companies. The Global Fund for AIDS, TB and Malaria is an official participant in Smart Health Hub, as is SafePoint Single-Use Syringes, and it also has the support of the World Health Organisation (WHO). Smart Health Hub is part of a wider range of mobile commerce, software and innovation that Mobilium has begun to bring to the entire African continent and rest of the world.
Glenn D. Steele Jr., MD, PhD
President and Chief Executive Officer
Geisinger Health System
Glenn D. Steele Jr., MD, PhD, is President and Chief Executive Officer of Geisinger Health System. Dr. Steele joined Geisinger Health System as President and Chief Executive Officer on March 1, 2001. He arrived at Geisinger from the University of Chicago, where he served as Richard T. Crane Professor in the Department of Surgery, Vice President for Medical Affairs, and Dean of the Division of Biological Sciences Division and the Pritzker School of Medicine. Prior to that, he was the William V. McDermott Professor of Surgery at Harvard Medical School, President and Chief Executive Officer of Deaconess Professional Practice Group and Chairman of the Department of Surgery at New England Deaconess Hospital. Widely recognized for his investigations into the treatment of primary and metastatic liver cancer and colorectal cancer surgery, Dr. Steele is past Chairman of the American Board of Surgery. He serves on the editorial board of numerous prominent medical journals. His investigations have focused on the cell biology of gastrointestinal cancer and pre-cancer. Most recently, he has concentrated on innovations in healthcare delivery and financing. A prolific writer, he is the author or co-author of more than 460 scientific and professional articles.
Steven R. Steinhubl, MD
Director of Digital Medicine, Scripps Translational Science Institute
Clinical Cardiologist, Scripps Health
DR. Steinhubl is the Director of Digital Medicine at the Scripps Translational Science Institute and a clinical cardiologist at Scripps Health. He received his undergraduate training in engineering at Purdue University, graduate training in physiology at Georgetown University, and his medical degree at St. Louis University. Steve’s residency training was completed at David Grant USAF Medical Center and his cardiology fellowship at the Cleveland Clinic. Prior to joining Scripps Steve was the Director of Cardiovascular Wellness and the Medical Director for Employee Wellness for the Geisinger Healthcare System. Over Steve’s 15 year career as a clinician-scientist his research activities have focused on clinical trials that drive novel therapeutic interventions in order to improve outcomes. At Scripps, through the development and oversight of a portfolio of clinical trials, Steve is responsible for helping develop the evidence base necessary to establish the role of mobile health technologies in the transformation of healthcare. He has been dozens of clinical trials and has authored over 200 peer-reviewed manuscripts as well as numerous book chapters, and abstracts.
Venture Valkyrie Consulting
Lisa Suennen is Managing Partner at Venture Valkyrie Consulting, which provides business advisory services to companies, venture capital firms and non-profit organizations in the healthcare field. Lisa is a board member at Beyond Lucid Technologies, Pokitdok, Humetrix, and the Dignity Health Foundation. She is an advisory board member at HealthXL, Qualcomm Life and the California Healthcare Foundation. Lisa also writes Venture Valkyrie, a widely read blog on healthcare and investing. She has recently published her first book: Tech Tonics, Can Passionate Entrepreneurs Heal Healthcare with Technology. Previously, Lisa spent 15 years with Psilos Group, a healthcare-focused venture capital firm where she was a co-founder and Partner. Earlier, Lisa helped build Merit Behavioral Care, an $800mm behavioral healthcare company where she held various senior executive roles from its early start-up days through exit. Previously, Lisa held various positions in the high technology field. Lisa holds undergraduate and graduate degrees from UC Berkeley, where she is now on faculty at the Haas School of Business.
Euan is an operating partner at Khosla Ventures, where he focuses on healthcare. During his tenure at the firm, he has worked with Quanttus, CellScope, Zyomed, EyeNetra, Ginger.io, and Lumiata among many others. Euan currently serves as the interim CEO of Alivecor, which has developed a device that can turn any smartphone into a clinical-quality mobile heart monitor. Prior to joining Khosla Ventures, Euan had more than 14 years of experience as a CEO, managing both public and private companies.
Eric Topol, MD
Director, Scripps Translational Science Institute
Chief Academic Officer, Scripps Health
Professor of Genomics, The Scripps Research Institute
Voted as the #1 Most Influential Physician Executive in the United States in 2012 in a national poll conducted by Modern Healthcare, Dr. Topol works on genomic and wireless digital innovative technologies to reshape the future of medicine. He is a practicing cardiologist at Scripps in La Jolla, California and widely credited for leading the Cleveland Clinic to become the #1 center for heart care. While there he also started a new medical school, led many worldwide clinical trials to advance care for patients with heart disease, and spearheaded the discovery of multiple genes that increase susceptibility for heart attacks. Since 2006, in La Jolla, he leads the flagship NIH supported Scripps Translational Science. He also serves as Professor of Genomics at The Scripps Research Institute and Chief Academic Officer of Scripps Health. Topol pioneered the development of many medications that are routinely used in medical practice including t-PA, Plavix, Angiomax, and ReoPro and was the first physician to raise safety concerns on Vioxx. He has published over 1100 peer-reviewed articles and over 30 medical textbooks. In 2009, along with Francis Collins and Harold Varmus, Topol was selected to be one of the country’s 12 “Rock Stars of Science” in GQ Magazine. In 2011, the University of Michigan, where he had served on the faculty, initiated the Eric Topol Professor of Cardiovascular Medicine to recognize his contributions. The University of Rochester, his alma mater medical school, awarded him the Hutchinson Medal, the University’s highest honor. He was elected to the Institute of Medicine of the National Academy of Sciences and is one of the top 10 most cited researchers in medicine. His book The Creative Destruction of Medicine (Basic Books) was published in 2012 and has been the #1 bestseller in biotechnology, medical informatics, and medical practice on Amazon. He additionally took on the Editor-in-Chief position at Medscape in 2013 and the role of AT&T’s Chief Medical Advisor in 2014. His new book on democratizing medicine will be out in early 2015.
Vice President, Corporate Development and Strategic Investments
Sondra Tucker is Florida Blue’s vice president of Corporate Development and Strategic Investments. In this role, Tucker is responsible for providing direction and leadership for this fully integrated corporate development and portfolio management area, which evaluates and executes on strategic investment and other strategic partnership opportunities in support of strategic priorities and provides a holistic view of business and financial performance and systemic risks of joint ventures and subsidiaries. Since joining Florida Blue in 1999, Tucker has served in various leadership roles in finance. Most recently, Tucker served as the managing principal of the Corporate Development & Strategic Investment team of Florida Blue, where she was responsible for providing direction and leadership to business development initiatives including mergers/acquisitions, business consulting and strategic investments. Other previous roles with Florida Blue include senior director of Financial Performance & Analysis in the Finance Group, where she led financial forecasting, budgeting, cost allocation, benefit realization, performance reporting, financial analytics and external financial rating/investor relations. Prior to joining Florida Blue in 1999, Tucker spent 15 years working for three regional banking organizations where her assignments encompassed both operational and financial functions; including turn around opportunities. Her background includes strategic planning, corporate development, product development, marketing, customer acquisition and retention, contract negotiations, retail operations, credit analysis and auditing. Throughout her career, Tucker has been extremely active in her community. She has served in public service roles with the International Rotary Foundation, Rainbow Center for Communicative Disorders, Ronald McDonald House Parent Net Program, United Way, Morning Star School and Grove House Supportive Services. Tucker holds a Bachelor of Science in Accounting and Finance from Avila University and a Master of Business Administration from the University of North Florida. She is also Certified Public Accountant in the state of Florida.
Member of the Firm
Epstein Becker & Green, P.C.
Kim Tyrrell-Knott is the co-chair of the EBG Connected Health Practice and a leader of the FDA and Medical Technology service team at the firm. Ms. Tyrrell-Knott regularly advises technology companies and new entrants to the health care market on a broad range of health care regulatory issues. She is actively involved in policy development in the health IT industry and serves as General Counsel to the mHealth Regulatory Coalition and the Clinical Decision Support Coalition. Prior to joining
EBG, Ms. Tyrrell-Knott was in-house at a number of healthcare and technology companies, including GE Healthcare, where she supported its Healthcare IT business globally.
Jordan VanLare, MD
Associate Partner, Health Systems and Services Practice
McKinsey & Company
Jordan is an Associate Partner in McKinsey’s New Jersey office. He is an expert in healthcare value and helps lead the development of alternative payment models within the Health Systems and Services Practice. Areas of expertise: Jordan serves public and private payors on a variety of topics in strategy, payment and pricing, and health information technology. In particular, he focuses on value-based payment model design and implementation. He also advises innovators and manufactures on the implications of value-based payment models. Relevant experience: Jordan recently led CMS’ value-based purchasing efforts in the Center for Clinical Standards and Quality. He is a past member of the Board of Trustees of the American Medical Association. Additionally, he has authored multiple peer-reviewed publications in journals including New England Journal of Medicine, JAMA, Health Affairs, and JAMA Internal Medicine. Educational background: Jordan received his M.D. from Columbia University, trained in medicine at Yale University, and was awarded his B.A. in biochemical sciences at Harvard University.
Conrad Wang, MD
Senior Director of Corporate Development
Conrad Wang is Senior Director of Corporate Development for Medtronic, plc. Conrad works in partnership with executive and business unit management in evaluating and executing mergers and acquisitions, strategic alliances, joint ventures, minority investments, technology licenses, divestitures and other strategic transactions. Prior to joining Medtronic, Conrad was an investor at Three Arch Partners, a healthcare venture capital firm. He also completed his residency in orthopedic surgery. Conrad has a BS from MIT, and an MD and MBA from Harvard.
Director, Health & Mobile Product Research
Harry Wang studies the consumer electronics and entertainment service industries with a focus on portable CE hardware, software, and associated applications and services. He is also the lead analyst for Parks Associates’ digital health research program. Harry has presented his research in numerous industry events including CES, Digital Hollywood, Photo Marketing Association Annual Show, American Telemedicine Association Annual Show, World Health Congress, and Parks Associates’ CONNECTIONS™ conferences.
Harry earned his MS degree in marketing research from the University of Texas at Arlington. He also holds an MBA degree in finance from Texas Christian University and a BA degree in international business from Guangdong University of Foreign Studies, P.R. China.
INDUSTRY EXPERTISE: Digital Health Products and Services, Portable and Mobile Access Platforms and Applications, Digital Imaging Products and Services
Yulun Wang, PhD
Founder, Chairman & CEO
Yulun Wang founded InTouch Health in 2002. Named one of the top 100 health companies in the US by Inc. magazine, InTouch develops telemedicine systems that let physicians diagnose and consult with patients from remote locations. Wang has long been a pioneer in medical technology with over 100 patents in his name. After earning his PhD in electrical engineering, he founded Computer Motion and invented the first FDA-approved surgical robot, known as Aesop, which was widely used in minimally invasive surgery. Computer Motion went public in 1997 and later merged with Intuitive Surgical. Wang has received numerous entrepreneurship and leadership awards and was elected to the National Academy of Engineering in 2011. He is on the board of directors at Hoag Memorial Hospital and the American Telemedicine Association and is a member of the Engineering Advisory Board at UC Santa Barbara.
President & CEO
North Dakota-born Shane Waslaski is President/CEO at Intelligent InSites – the leading provider of operational intelligence for healthcare. Prior to joining Intelligent InSites in May 2014, he was President of Varistar, where he led a manufacturing and infrastructure business portfolio with 1,600 employees and revenues of more than $500M. Varistar is a management and holding subsidiary of Otter Tail Corporation (NASDAQ: OTTR), where Shane also served as a corporate officer and SVP. Prior to Varistar, Shane spent 8 years working in leadership roles in healthcare operations (Children’s Hospitals and Clinics, Minneapolis/St. Paul; Family HealthCare, Fargo), and providing operations consulting to healthcare customers. His roles have spanned from ERP integration engagements, emergency department studies, facility expansion planning, operational re-engineering work, and Interim President/CEO roles. Shane has also served on numerous volunteer boards, including the ND State Board of Higher Education and The Village Family Service Center. He has also been a Hospice of the Red River Valley Volunteer. Currently he is serving on the Board for Junior Achievement of the Upper Midwest (JAUM) and is the past chair of Junior Achievement of the Upper Red River Valley based in Fargo, ND for which he continues to volunteer in elementary classrooms. Shane graduated with honors in 1998 from North Dakota State University, with degrees in Biochemistry and Zoology.